Mechanisms of Upper Airway Obstruction
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 133 people enrolled
- Started
- 3 Jun 2020
- Ended
- 10 May 2024
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Hypoglossal Nerve Stimulation
- Record updated
- 21 January 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Other criteria
- Study A Inclusion Criteria:
- Scheduled to undergo DISE as part of routine clinical standard of care; Study B Inclusion Criteria:
- Adults (≥ 22yrs) willing and capable of providing informed consent
- Implanted with the MRI-conditional Inspire hypoglossal nerve stimulator (Model 3028 or later)
- Compliant with Inspire therapy (> 20 hours/week over 2+ weeks) as a standalone treatment for sleep-disordered breathing
- Inspire remote model 2500 or later; Study B Exclusion Criteria:
- MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)
- Inspire Implant Model 3024
- Inspire Remote Model 3032
- Patients who have fallen asleep while during resulting in an accident or "near miss" accident within 1 year prior to device implantation
- Inability to sleep in the supine position (by self-report)
- History of severe difficulty initiating or maintaining sleep in the laboratory
- Pregnant women
Where in United States
- Pennsylvania HospitalPhiladelphia, United States
About the trial
What the trial wants to find out
The current study is designed to examine underlying mechanisms of action of lingual muscles in the maintenance of airway patency during sleep. The investigators' major hypothesis is that specific tongue muscles are responsible for relieving upper airway obstruction during sleep.
The 3 groups in the trial
- Study A - Functional Phenotyping during DISENo study treatment, for comparison
Participants with diagnosed OSA undergo Drug-Induced Sleep Endoscopy (DISE) to characterize determinants of upper airway obstruction using CPAP and pharyngeal manometry. Jaw thrust and other positional maneuvers are performed during DISE as part of routine clinical standard of care.
- Study B - HGNS RespondersTreatment being tested
Participants with implanted Inspire HGNS devices undergo DISE and overnight polysomnography to assess upper airway responses with and without HGNS stimulation. CPAP titration is performed during DISE. Upper airway MRI and tongue force assessments are also conducted. Response was defined by a ≥ 50% reduction in AHI with stimulation.
Treatment: Hypoglossal Nerve Stimulation
- Study B - HGNS NonrespondersTreatment being tested
Participants with implanted Inspire HGNS devices undergo DISE and overnight polysomnography to assess upper airway responses with and without HGNS stimulation. CPAP titration is performed during DISE. Upper airway MRI and tongue force assessments are also conducted. Nonresponse was defined by a \< 50% reduction in AHI with stimulation.
Treatment: Hypoglossal Nerve Stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterizing Mechanisms of Upper Airway Obstruction During Drug-Induced Sleep Endoscopy (DISE)
- Record updated
- 21 January 2026